These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35971987)

  • 1. Effective mitigation of gadolinium deposition using the bidentate hydroxypyridinone ligand Me-3,2-HOPO.
    Sun Q; Wang X; Shi C; Guan J; Chen L; Wang Y; Wang S; Diwu J
    Dalton Trans; 2022 Aug; 51(34):13055-13060. PubMed ID: 35971987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents.
    Datta A; Raymond KN
    Acc Chem Res; 2009 Jul; 42(7):938-47. PubMed ID: 19505089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thorium(IV) complexes of bidentate hydroxypyridinonates.
    Xu J; Whisenhunt DW; Veeck AC; Uhlir LC; Raymond KN
    Inorg Chem; 2003 Apr; 42(8):2665-74. PubMed ID: 12691574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New agents for in vivo chelation of uranium(VI): efficacy and toxicity in mice of multidentate catecholate and hydroxypyridinonate ligands.
    Durbin PW; Kullgren B; Xu J; Raymond KN
    Health Phys; 1997 Jun; 72(6):865-79. PubMed ID: 9169929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of homochiral tris(2-alkyl-2-aminoethyl)amine derivatives from chiral alpha-amino aldehydes and their application in the synthesis of water soluble chelators.
    Hajela SP; Johnson AR; Xu J; Sunderland CJ; Cohen SM; Caulder DL; Raymond KN
    Inorg Chem; 2001 Jun; 40(13):3208-16. PubMed ID: 11399194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chelating agents for uranium(VI): 2. Efficacy and toxicity of tetradentate catecholate and hydroxypyridinonate ligands in mice.
    Durbin PW; Kullgren B; Ebbe SN; Xu J; Raymond KN
    Health Phys; 2000 May; 78(5):511-21. PubMed ID: 10772024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.
    Xu J; Churchill DG; Botta M; Raymond KN
    Inorg Chem; 2004 Sep; 43(18):5492-4. PubMed ID: 15332797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific sequestering agents for the actinides. 28. Synthesis and initial evaluation of multidentate 4-carbamoyl-3-hydroxyl-1-methyl-2(1H)-pyridinone ligands for in vivo plutonium(IV) chelation.
    Xu J; Kullgren B; Durbin PW; Raymond KN
    J Med Chem; 1995 Jul; 38(14):2606-14. PubMed ID: 7629800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ligand scaffold size on the stability of tripodal hydroxypyridonate gadolinium complexes.
    O'Sullivan B; Doble DM; Thompson MK; Siering C; Xu J; Botta M; Aime S; Raymond KN
    Inorg Chem; 2003 Apr; 42(8):2577-83. PubMed ID: 12691564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses and relaxation properties of mixed gadolinium hydroxypyridinonate MRI contrast agents.
    Cohen SM; Xu J; Radkov E; Raymond KN; Botta M; Barge A; Aime S
    Inorg Chem; 2000 Dec; 39(25):5747-56. PubMed ID: 11151375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,2-Hydroxypyridinone-Grafted Chitosan Oligosaccharide Nanoparticles as Efficient Decorporation Agents for Simultaneous Removal of Uranium and Radiation-Induced Reactive Oxygen Species in Vivo.
    Shi C; Wang X; Wan J; Zhang D; Yi X; Bai Z; Yang K; Diwu J; Chai Z; Wang S
    Bioconjug Chem; 2018 Nov; 29(11):3896-3905. PubMed ID: 30372621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 3,2-Hydroxypyridinone-based Decorporation Agent that Removes Uranium from Bones In Vivo.
    Wang X; Dai X; Shi C; Wan J; Silver MA; Zhang L; Chen L; Yi X; Chen B; Zhang D; Yang K; Diwu J; Wang J; Xu Y; Zhou R; Chai Z; Wang S
    Nat Commun; 2019 Jun; 10(1):2570. PubMed ID: 31239437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexadentate hydroxypyridonate iron chelators based on TREN-Me-3,2-HOPO: variation of cap size.
    Xu J; O'Sullivan B; Raymond KN
    Inorg Chem; 2002 Dec; 41(25):6731-42. PubMed ID: 12470069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A highly stable gadolinium complex with a fast, associative mechanism of water exchange.
    Thompson MK; Botta M; Nicolle G; Helm L; Aime S; Merbach AE; Raymond KN
    J Am Chem Soc; 2003 Nov; 125(47):14274-5. PubMed ID: 14624565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomimetic actinide chelators: an update on the preclinical development of the orally active hydroxypyridonate decorporation agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO).
    Abergel RJ; Durbin PW; Kullgren B; Ebbe SN; Xu J; Chang PY; Bunin DI; Blakely EA; Bjornstad KA; Rosen CJ; Shuh DK; Raymond KN
    Health Phys; 2010 Sep; 99(3):401-7. PubMed ID: 20699704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidentate hydroxypyridinonate ligands for Pu(IV) chelation in vivo: comparative efficacy and toxicity in mouse of ligands containing 1,2-HOPO or Me-3,2-HOPO.
    Durbin PW; Kullgren B; Xu J; Raymond KN
    Int J Radiat Biol; 2000 Feb; 76(2):199-214. PubMed ID: 10716641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and initial evaluation for in vivo chelation of Pu(IV) of a mixed octadentate spermine-based ligand containing 4-carbamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone and 6-carbamoyl-1-hydroxy-2(1H)-pyridinone.
    Xu J; Durbin PW; Kullgren B; Ebbe SN; Uhlir LC; Raymond KN
    J Med Chem; 2002 Aug; 45(18):3963-71. PubMed ID: 12190318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward optimized high-relaxivity MRI agents: thermodynamic selectivity of hydroxypyridonate/catecholate ligands.
    Pierre VC; Melchior M; Doble DM; Raymond KN
    Inorg Chem; 2004 Dec; 43(26):8520-5. PubMed ID: 15606201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivity.
    Floyd WC; Klemm PJ; Smiles DE; Kohlgruber AC; Pierre VC; Mynar JL; Fréchet JM; Raymond KN
    J Am Chem Soc; 2011 Mar; 133(8):2390-3. PubMed ID: 21294571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly luminescent and stable hydroxypyridinonate complexes: a step towards new curium decontamination strategies.
    Sturzbecher-Hoehne M; Kullgren B; Jarvis EE; An DD; Abergel RJ
    Chemistry; 2014 Aug; 20(32):9962-8. PubMed ID: 25043376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.